Comment
doi: 10.1056/NEJMc1405715.
Spironolactone for heart failure with preserved ejection fraction
- PMID: 25006730
- DOI: 10.1056/NEJMc1405715
Item in Clipboard
Comment
Spironolactone for heart failure with preserved ejection fraction
N Engl J Med.
.
Free article
No abstract available
Comment in
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):181-2. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006726 No abstract available.
Comment on
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731. N Engl J Med. 2014. PMID: 24716680 Clinical Trial.
-
Lessons from the TOPCAT trial.N Engl J Med. 2014 Apr 10;370(15):1453-4. doi: 10.1056/NEJMe1401231. N Engl J Med. 2014. PMID: 24716685 No abstract available.
Similar articles
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):180. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006729 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):179-80. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006728 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):179. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006727 No abstract available.
-
Effect of Mineralocorticoid Receptor Antagonists in Individuals With Heart Failure With Preserved Ejection Fraction: A Systematic Review.J Card Fail. 2018 Sep;24(9):618-621. doi: 10.1016/j.cardfail.2018.08.006. Epub 2018 Sep 5. J Card Fail. 2018. PMID: 30194985 No abstract available.
-
Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?Curr Atheroscler Rep. 2015 Nov;17(11):64. doi: 10.1007/s11883-015-0541-6. Curr Atheroscler Rep. 2015. PMID: 26408016 Review.
Cited by
-
Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.Front Cardiovasc Med. 2022 May 4;9:875327. doi: 10.3389/fcvm.2022.875327. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35600478 Free PMC article.
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 May 22;5:CD012721. doi: 10.1002/14651858.CD012721.pub3. PMID: 29952095 Free PMC article. Updated.
-
Pharmacological interventions for heart failure in people with chronic kidney disease.Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2. Cochrane Database Syst Rev. 2020. PMID: 32103487 Free PMC article.
-
Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.PLoS One. 2019 Apr 4;14(4):e0214907. doi: 10.1371/journal.pone.0214907. eCollection 2019. PLoS One. 2019. PMID: 30947284 Free PMC article.
-
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4. Cochrane Database Syst Rev. 2020. PMID: 33107592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
